孟德尔随机化
肺癌
邦费罗尼校正
医学
肿瘤科
内科学
遗传学
生物
基因型
基因
统计
数学
遗传变异
作者
Ming Xu,Chengkai Li,Lei Xiang,Siyue Chen,Lin Chen,Ling Gao,Yougen Hu,Lan Yang,Xiang Yuan,Xiaodong Xia,Hailin Zhang
出处
期刊:BMC Cancer
[Springer Nature]
日期:2024-02-26
卷期号:24 (1)
被引量:2
标识
DOI:10.1186/s12885-024-12014-1
摘要
Abstract Background Previous studies have observed a link between immunophenotypes and lung cancer, both of which are closely associated with genetic factors. However, the causal relationship between them remains unclear. Methods Bidirectional Mendelian randomization (MR) was performed on publicly available genome-wide association study (GWAS) summary statistics to analyze the causal relationships between 731 immunophenotypes and lung cancer. Sensitivity analyses were conducted to verify the robustness, heterogeneity, and potential horizontal pleiotropy of our findings. Results Following Bonferroni adjustment, CD14 − CD16 + monocyte (OR = 0.930, 95%CI 0.900–0.960, P = 8.648 × 10 − 6 , P Bonferroni = 0.006) and CD27 on CD24 + CD27 + B cells (OR = 1.036, 95%CI 1.020–1.053, P = 1.595 × 10 − 5, P Bonferroni = 0.012) were identified as having a causal role in lung cancer via the inverse variance weighted (IVW) method. At a more relaxed threshold, CD27 on IgD + CD24 + B cell (OR = 1.035, 95%CI 1.017–1.053, P = 8.666 × 10 − 5 , P Bonferroni = 0.063) and CD27 on switched memory B cell (OR = 1.037, 95%CI 1.018–1.056, P = 1.154 × 10 − 4 , P Bonferroni = 0.084) were further identified. No statistically significant effects of lung cancer on immunophenotypes were found. Conclusions The elevated level of CD14 − CD16 + monocytes was a protective factor against lung cancer. Conversely, CD27 on CD24 + CD27 + B cell was a risk factor. CD27 on class-switched memory B cells and IgD + CD24 + B cells were potential risk factors for lung cancer. This research enhanced our comprehension of the interplay between immune responses and lung cancer risk. Additionally, these findings offer valuable perspectives for the development of immunologically oriented therapeutic strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI